A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects
Clinical trial NCT05763459 · COMPLETED
Trial details
- NCT number
- NCT05763459
- Sponsor
- Calico Life Sciences LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-24
- Primary completion
- 2023-05-08
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.